scholarly journals 0-Is type small advanced colorectal cancer of less than 20mm: a case report

2018 ◽  
Vol 93 (1) ◽  
pp. 128-130
Author(s):  
Takehiro Yoshii ◽  
Masanori Takahashi ◽  
Kei Funada ◽  
Taira Sato ◽  
Iichiro Ohtsu ◽  
...  
Keyword(s):  
Colorectal Cancer ◽  
Case Report ◽  
Advanced Colorectal Cancer

scholarly journals Advanced colorectal cancer resulting in acute bowel obstruction during pregnancy; a case report

2016 ◽  
Vol 8 ◽  
pp. 18-20 ◽  
Author(s):  
Rikkert R. Ossendorp ◽  
Rob Silvis ◽  
Gerben J. van der Bij
Keyword(s):  
Colorectal Cancer ◽  
Case Report ◽  
Bowel Obstruction ◽  
Advanced Colorectal Cancer

scholarly journals Advanced Colorectal Cancer Complicated by Takotsubo Cardiomyopathy During mFOLFOX6 Therapy: A Case Report

2015 ◽  
Vol 68 (2) ◽  
pp. 103-108
Author(s):  
Momoko Kogo ◽  
Shintaro Nakajima ◽  
Yoshiko Uno ◽  
Mitsumasa Takeda ◽  
Kenta Tomori ◽  
...  
Keyword(s):  
Colorectal Cancer ◽  
Case Report ◽  
Takotsubo Cardiomyopathy ◽  
Advanced Colorectal Cancer

scholarly journals Dysphonia after Bevacizumab Rechallenge: A Case Report

2015 ◽  
Vol 8 (3) ◽  
pp. 423-425 ◽  
Author(s):  
Corey A. Carter ◽  
Scott Z. Caroen ◽  
Arnold L. Oronsky ◽  
Bryan T. Oronsky
Keyword(s):  
Colorectal Cancer ◽  
Case Report ◽  
Advanced Colorectal Cancer ◽  
Vascular Endothelial ◽  
Standard Chemotherapy ◽  
Vegf Signaling ◽  
First Case ◽  
Voice Changes ◽  
Endothelial Growth Factor ◽  
Tumor Growth And Invasion

Inhibition of vascular endothelial growth factor (VEGF) signaling, an initiator of tumor angiogenesis, inhibits tumor growth and invasion. Bevacizumab, a monoclonal antibody to VEGF, in common use as an adjunct to standard chemotherapy like irinotecan in advanced colorectal cancer, also affects the normal (nontumor) vasculature. Dysphonia or voice changes have been anecdotally reported in patients that have been exposed to antiangiogenics. In this case report, we present an occurrence of severe dysphonia in a 60-year-old male with metastatic colorectal cancer after reintroduction of irinotecan and bevacizumab. To our knowledge, this is the first case of dysphonia associated with bevacizumab rechallenge.

scholarly journals Long‐term survival of an advanced colorectal cancer patient treated with Regorafenib: Case report and literature review

2019 ◽  
Vol 7 (12) ◽  
pp. 2379-2383 ◽  
Author(s):  
Oronzo Brunetti ◽  
Angela Calabrese ◽  
Loredana Palermo ◽  
Antonio Giovanni Solimando ◽  
Antonella Argentiero
Keyword(s):  
Colorectal Cancer ◽  
Case Report ◽  
Literature Review ◽  
Cancer Patient ◽  
Advanced Colorectal Cancer ◽  
Colorectal Cancer Patient ◽  
Term Survival ◽  
Long Term Survival ◽  
Advanced Colorectal Cancer Patient

scholarly journals Destructive soft tissue metastases in advanced colorectal cancer: a case report

2021 ◽  
Vol 0 (0) ◽  
pp. 0-0
Author(s):  
Michael S. Krasovitsky ◽  
David Goldstein
Keyword(s):  
Colorectal Cancer ◽  
Case Report ◽  
Soft Tissue ◽  
Advanced Colorectal Cancer

scholarly journals IIa + IIc type small advanced colorectal cancer with lymph node metastasis : a case report

2017 ◽  
Vol 90 (1) ◽  
pp. 132-133
Author(s):  
Iichiro Ohtsu ◽  
Ryo Chinzei ◽  
Masanori Takahashi ◽  
Kei Funada ◽  
Taira Sato ◽  
...  
Keyword(s):  
Colorectal Cancer ◽  
Case Report ◽  
Lymph Node ◽  
Lymph Node Metastasis ◽  
Advanced Colorectal Cancer ◽  
Node Metastasis

Efficacy of Combining Chemotherapy and Nimotuzumab for the Treatment of Advanced Colorectal Cancer with Multiple Organ Metastases: A Case Report

Cureus ◽  
2011 ◽  
Author(s):  
Xia Li ◽  
Xiangyu Kong ◽  
Shurong Yuan ◽  
Bing Liang ◽  
Yuntao Dai ◽  
...  
Keyword(s):  
Colorectal Cancer ◽  
Case Report ◽  
Advanced Colorectal Cancer ◽  
Multiple Organ
Sign in / Sign up

Export Citation Format

Share Document